USA - NYSE:BSX - US1011371077 - Common Stock
We assign a fundamental rating of 6 out of 10 to BSX. BSX was compared to 191 industry peers in the Health Care Equipment & Supplies industry. BSX scores excellent on profitability, but there are some minor concerns on its financial health. BSX is growing strongly while it is still valued neutral. This is a good combination! With these ratings, BSX could be worth investigating further for growth investing!.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 6.03% | ||
ROE | 11.17% | ||
ROIC | 7.66% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 18.69% | ||
PM (TTM) | 13.54% | ||
GM | 68.3% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.5 | ||
Debt/FCF | 3.33 | ||
Altman-Z | 5.38 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.37 | ||
Quick Ratio | 0.82 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 34.38 | ||
Fwd PE | 28.35 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 41.38 | ||
EV/EBITDA | 32.2 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
NYSE:BSX (10/15/2025, 2:50:07 PM)
97.3
+1.06 (+1.1%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 34.38 | ||
Fwd PE | 28.35 | ||
P/S | 7.8 | ||
P/FCF | 41.38 | ||
P/OCF | 33.65 | ||
P/B | 6.43 | ||
P/tB | N/A | ||
EV/EBITDA | 32.2 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 6.03% | ||
ROE | 11.17% | ||
ROCE | 9.51% | ||
ROIC | 7.66% | ||
ROICexc | 7.77% | ||
ROICexgc | 26.52% | ||
OM | 18.69% | ||
PM (TTM) | 13.54% | ||
GM | 68.3% | ||
FCFM | 18.84% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.5 | ||
Debt/FCF | 3.33 | ||
Debt/EBITDA | 2.33 | ||
Cap/Depr | 60.84% | ||
Cap/Sales | 4.33% | ||
Interest Coverage | 250 | ||
Cash Conversion | 89.77% | ||
Profit Quality | 139.08% | ||
Current Ratio | 1.37 | ||
Quick Ratio | 0.82 | ||
Altman-Z | 5.38 |